Skip to main content
AG

AgeCurve

Cambridge, United Kingdom
Last funding
$313K
SeedFeb 2024

AgeCurve is a biotechnology company that uses evolutionary cell lineage trees to unlock the predictive power somatic mutations.

Backed byLongevitytech.fund

About AgeCurve

How much funding has AgeCurve raised?

AgeCurve has raised $313K in total funding. The most recent round was Seed. The last funding was announced in February 2024.

Who are AgeCurve's investors?

AgeCurve's investors include Longevitytech.fund.

Where is AgeCurve headquartered?

AgeCurve is headquartered in Cambridge, United Kingdom.

What does AgeCurve do?

AgeCurve is a biotechnology company that uses evolutionary cell lineage trees to unlock the predictive power somatic mutations.

What stage is AgeCurve at?

AgeCurve is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"AgeCurve — Funding & Investors." VCBacked, February 5, 2024, https://www.vcbacked.co/company/agecurve. Accessed November 21, 2026.
APA
VCBacked. (2024). AgeCurve — Funding & Investors. Retrieved November 21, 2026, from https://www.vcbacked.co/company/agecurve
Wikipedia (cite web)
{{cite web |title=AgeCurve — Funding & Investors |url=https://www.vcbacked.co/company/agecurve |website=VCBacked |access-date=November 21, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at AgeCurve? Request a listing update

Founder contacts
m***@agecurve.co.uk
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →